Eventide Healthcare & Life Sciences Fund Class A Shares (ETAHX)
| Fund Assets | 1.66B |
| Expense Ratio | 1.57% |
| Min. Investment | $1,000 |
| Turnover | 41.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 48.08 |
| YTD Return | -4.49% |
| 1-Year Return | 66.54% |
| 5-Year Return | 6.07% |
| 52-Week Low | 26.02 |
| 52-Week High | 51.61 |
| Beta (5Y) | n/a |
| Holdings | 92 |
| Inception Date | Dec 27, 2012 |
About ETAHX
Eventide Healthcare & Life Sciences Fund Class A is an actively managed sector equity fund focused on healthcare and life sciences. Its primary purpose is to provide long-term capital appreciation by investing in companies that demonstrate ethical, sustainable business practices and offer attractive investment opportunities. The fund concentrates on biotechnology, pharmaceuticals, and other healthcare-related sectors, aligning with values-driven investment strategies. It plays a significant role in the financial market by offering investors a specialized portfolio that targets cutting-edge healthcare solutions. The fund's approach is distinguished by its emphasis on early-stage companies, including biotech firms and specialty drug developers, which positions it as a high-risk, high-reward option within its niche.
Performance
ETAHX had a total return of 66.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.56%.
Top 10 Holdings
31.46% of assets| Name | Symbol | Weight |
|---|---|---|
| Guardant Health, Inc. | GH | 4.46% |
| Belite Bio, Inc | BLTE | 3.63% |
| Mirum Pharmaceuticals, Inc. | MIRM | 3.60% |
| Beta Bionics, Inc. | BBNX | 3.41% |
| Insmed Incorporated | INSM | 3.15% |
| Kymera Therapeutics, Inc. | KYMR | 2.88% |
| Ionis Pharmaceuticals, Inc. | IONS | 2.69% |
| ABIVAX Société Anonyme | ABVX | 2.62% |
| Us Bank Mmda - Usbgfs 9 | n/a | 2.51% |
| Scholar Rock Holding Corporation | SRRK | 2.49% |